4th Quarter - Termination

RICCHETTI INCORPORATED for VAXART INC.

Firm
Client
Income
$80,000
Expenses
—
Terminated
Dec 31, 2022

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Legislative and regulatory policies regarding oral vaccine development and funding

LobbyistCovered position, as disclosed
JEFF RICCHETTI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.